	Prevalence and factors associated with treatment delay among colorectal cancer patients at Mulago National Referral Hospital and the Uganda Cancer Institute: A cross-sectional study. PLoS One Kasagga B, Ssempebwa P, Kikuba G, E Egbe F, Nsodi PC, Kayaga J, Elobu EA, Okeny P. PMID: 42467652 [PubMed - indexed for MEDLINE]
	Neoadjuvant Imatinib Therapy in Rectal Gastrointestinal Stromal Tumors: A Comprehensive Narrative Review of Tumor Downsizing, Sphincter Preservation, Transanal Surgical Platforms, Functional Outcomes, and Survival. J Gastrointest Cancer Raja NP, Kandagari N. PMID: 42467291 [PubMed - indexed for MEDLINE]
	Clinical target volume radiomics from planning CT for pretreatment responseÂ prediction Â in rectal cancer undergoing chemoradiotherapy. Strahlenther Onkol Huang YC, Huang SM, Yeh JH, Tu SJ. PMID: 42467205 [PubMed - as supplied by publisher]
	Evaluating the usefulness of 18F-FDG PET/MR in rectal cancer staging: a prospective comparison with histopathological findings. Int J Colorectal Dis Maksim R, Hempel D, Mojsak M, , Zuzda K, Gugnacki P, Sidorkiewicz I, Sierko E. PMID: 42467114 [PubMed - as supplied by publisher]
	Predictability of peripheral blood inflammatory markers in prediction of lymph node metastasis in gastric cancer. Ther Adv Gastroenterol Li X, Dai W, Li X, Chen X, Chen Y, Fu Z, Zhang J. PMID: 42466441 [PubMed]
	Potential Targets in Innate Immunity Receptors for Gastric Cancer: Insights from Virtual Screening in TCM and In Vitro Assay. Avicenna J Med Biotechnol Ganjali A, Fakheri B, Bahari A, Fahmideh L, Valadan R, Tavakolizadeh M. PMID: 42466367 [PubMed]
	Functional and Participation Outcomes of Colorectal Cancer With Peritoneal Metastasis and Pseudomyxoma Peritonei Following Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS-HIPEC): A Cross-Sectional Survivorship Study. Adv Rehabil Sci Pract Yang M, Amatya B, Elmalik A, Song K, Mohan H, Heriot A, Khan F. PMID: 42466163 [PubMed]
	Preoperative inflammatory and immune-nutritional markers and postoperative pulmonary complications after gastric and colorectal cancer surgery: a systematic review and narrative synthesis. Front Surg Zhang H, Zou L, Fang H, Wang H. PMID: 42465867 [PubMed]
	Editorial: National colorectal cancer awareness month 2025: current progress and future prospects on colorectal cancer prevention, diagnosis and treatment. Front Oncol Passardi A, Gibbons D, Ricciardi R, Gurzu S. PMID: 42465568 [PubMed]
	Prostate Cancer Screening: Current Controversies and Future Directions. Cureus Buali HF, Al Shaibani A, Farouqi US, Abushloa T, Bastawisy A, Aljeeran N, Albenjasim K, Rafie M. PMID: 42465149 [PubMed]
	Postoperative Complications After Indocyanine Green-Guided Colorectal Cancer Surgery: Report of an Unexpected Severity Signal From a Prospective Cohort Study With Cluster-Based Allocation. Cureus Misca MC, Catrina E, Aldoescu S, Vilcu M, Boanta DR, Brezean I. PMID: 42465134 [PubMed]
	Construction of risk predictive models for postoperative hyponatremia in colorectal cancer patients. Am J Cancer Res Ni T, Su Y, Chen Q, Rao G, Liang Q, Pan W, Meng J, Zhong H. PMID: 42465014 [PubMed]
	Prognostic value of salt-inducible kinase 2 expression in advanced hepatocellular carcinoma treated with sorafenib or lenvatinib: a propensity score-matched cohort study. Am J Cancer Res Fu Q, Wang X, Zheng S, Wang W. PMID: 42465003 [PubMed]
	Gut Microbiome Alterations in Cancer and Non-cancer Adults: A Cross-Sectional Metagenomic Study. Technol Cancer Res Treat Hazan S, Bao G, Goudzwaard A, Ichim T, Martin L, Vidal AC. PMID: 42464944 [PubMed - indexed for MEDLINE]
	Prognostic Performance of Lymph Node Ratio and Log Odds of Positive Lymph Nodes in Colorectal Cancer: A Comparative Analysis with pN Stage. Ann Ital Chir Arg, Sunar AO, Bezir N, Akin MI, Kandaz ÖF, Ertugrul I, Polat E, Duman M. PMID: 42464841 [PubMed - indexed for MEDLINE]
	A Guideline-Concordant Chatbot Framework for Structured Colorectal Cancer Screening: Multistage Feasibility Study. J Med Internet Res Wu F, Li X, Zeng Y, Tang Y, Xiao Z, Yang S, Wu K, Liu S, Li A. PMID: 42464799 [PubMed - indexed for MEDLINE]
	Early prediction of minimal residual disease in colorectal cancer via SEPTIN9 methylation status in circulating tumor DNA. Ann Med Wang P, Peng L, Hu X, Liu Y, Jiang T, Yin W, Wu S, Lin J. PMID: 42464785 [PubMed - indexed for MEDLINE]
	Diagnosing carcinoma origin in ultrasound-guided needle biopsies: a context-driven approach anchored in site-specific immunohistochemical markers. Diagn Pathol Hermann G, Ghica R, Buiga R, Cebotaru I, Coza D, Sparchez Z. PMID: 42464336 [PubMed - as supplied by publisher]
	Cancer risk in patients with nontuberculous mycobacterial pulmonary disease: a nationwide population-based cohort study. Respir Res Lee C, Choi HK, Lee HH, Kang YA, Kim EY, Kim HW, Shin N, Park Y. PMID: 42464269 [PubMed - as supplied by publisher]
	Study protocol of the C-SOLVE (JACCRO GC-12) trial; a randomized, non-comparative phase II trial of CapeOX or SOX plus zolbetuximab in HER2-negative, CLDN18.2-positive unresectable advanced gastric or esophagogastric junction cancer. BMC Cancer Yuki S, Kawakami H, Harada K, Kubota Y, Pak K, Kakeji Y, Terashima M, Baba E, Muro K, Sunakawa Y, Ichikawa W, Fujii M. PMID: 42464196 [PubMed - as supplied by publisher]

Articles 1 - 20 / 242640

Page 1 of 12132



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy